メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
1 Drug-Eluting Stents Market Overview
1.1 Drug-Eluting Stents Product Overview
1.2 Drug-Eluting Stents Market Segment by Type
1.2.1 Rapamycin
1.2.2 Paclitaxel
1.2.3 Everolimus
1.2.4 Others
1.3 Global Drug-Eluting Stents Market Size by Type
1.3.1 Global Drug-Eluting Stents Sales and Growth by Type
1.3.2 Global Drug-Eluting Stents Sales and Market Share by Type (2015-2020)
1.3.3 Global Drug-Eluting Stents Revenue and Market Share by Type (2015-2020)
1.3.4 Global Drug-Eluting Stents Price by Type (2015-2020)
2 Global Drug-Eluting Stents Market Competition by Company
2.1 Global Drug-Eluting Stents Sales and Market Share by Company (2015-2020)
2.2 Global Drug-Eluting Stents Revenue and Share by Company (2015-2020)
2.3 Global Drug-Eluting Stents Price by Company (2015-2020)
2.4 Global Top Players Drug-Eluting Stents Manufacturing Base Distribution, Sales Area, Product Types
2.5 Drug-Eluting Stents Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stents Market Concentration Rate
2.5.2 Global Drug-Eluting Stents Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Drug-Eluting Stents Company Profiles and Sales Data
3.1 Boston Scientific
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Drug-Eluting Stents Product Category, Application and Specification
3.1.3 Boston Scientific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.1.4 Main Business Overview
3.2 Medtronic, Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Drug-Eluting Stents Product Category, Application and Specification
3.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.2.4 Main Business Overview
3.3 Abbott
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Drug-Eluting Stents Product Category, Application and Specification
3.3.3 Abbott Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.3.4 Main Business Overview
3.4 Lepu Medical
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Drug-Eluting Stents Product Category, Application and Specification
3.4.3 Lepu Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.4.4 Main Business Overview
3.5 MicroPort Scientific Corporation
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Drug-Eluting Stents Product Category, Application and Specification
3.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.5.4 Main Business Overview
3.6 Cook Medical
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Drug-Eluting Stents Product Category, Application and Specification
3.6.3 Cook Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.6.4 Main Business Overview
3.7 Terumo
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Drug-Eluting Stents Product Category, Application and Specification
3.7.3 Terumo Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.7.4 Main Business Overview
3.8 Biosensors International
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Drug-Eluting Stents Product Category, Application and Specification
3.8.3 Biosensors International Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.8.4 Main Business Overview
3.9 Balton
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Drug-Eluting Stents Product Category, Application and Specification
3.9.3 Balton Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.9.4 Main Business Overview
3.10 AlviMedica Medical Technologies
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Drug-Eluting Stents Product Category, Application and Specification
3.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Revenue, Price and Gross Margin(2015-2020)
3.10.4 Main Business Overview
3.11 Biotronik
3.12 Shandong JW Medical
3.13 Sino Medical
3.14 Beijing AMSINO
3.15 Liaoning Biomedical Materials R&D Center Co., Ltd. (LBC)
4 Drug-Eluting Stents Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Drug-Eluting Stents Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Drug-Eluting Stents Sales and Revenue by Regions
4.2.1 Global Drug-Eluting Stents Sales and Market Share by Regions (2015-2020)
4.2.2 Global Drug-Eluting Stents Revenue and Market Share by Regions (2015-2020)
4.2.3 Global Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 North America Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Drug-Eluting Stents Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Drug-Eluting Stents Application/End Users
5.1 Drug-Eluting Stents Segment by Application
5.1.1 Angina Pectoris
5.1.2 Myocardial Infarction
5.2 Global Drug-Eluting Stents Product Segment by Application
5.2.1 Global Drug-Eluting Stents Sales by Application
5.2.2 Global Drug-Eluting Stents Sales and Market Share by Application (2015-2020)
6 Global Drug-Eluting Stents Market Forecast
6.1 Global Drug-Eluting Stents Sales, Revenue Forecast (2021-2028)
6.1.1 Global Drug-Eluting Stents Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Drug-Eluting Stents Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Drug-Eluting Stents Forecast by Regions
6.2.1 North America Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Drug-Eluting Stents Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Drug-Eluting Stents Forecast by Type
6.3.1 Global Drug-Eluting Stents Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Rapamycin Gowth Forecast
6.3.3 Paclitaxel Gowth Forecast
6.4 Drug-Eluting Stents Forecast by Application
6.4.1 Global Drug-Eluting Stents Sales Forecast by Application (2021-2028)
6.4.2 Global Drug-Eluting Stents Forecast in Angina Pectoris
6.4.3 Global Drug-Eluting Stents Forecast in Myocardial Infarction
7 Drug-Eluting Stents Upstream Raw Materials
7.1 Drug-Eluting Stents Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Drug-Eluting Stents Industrial Chain Analysis
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
